| Identification | Back Directory | [Name]
dactimicin | [CAS]
73196-97-1 | [Synonyms]
St 900
Sf-2052
dactimicin
Antibiotic SF-2052
Reaxys ID: 1410417
Formimidoyl-fortimicin A
4-Amino-1,4-dideoxy-3-O-(2,6-diamino-2,3,4,6,7-pentadeoxy-β-L-lyxo-heptopyranosyl)-1-[[[(iminomethyl)amino]acetyl]methylamino]-6-O-methyl-L-chiro-inositol
4-Amino-3-O-(2,6-diamino-2,3,4,6,7-pentadeoxy-β-L-lyxo-heptopyranosyl)-1-[[[(iminomethyl)amino]acetyl]methylamino]-6-O-methyl-1,4-dideoxy-L-chiro-inositol
L-Chiro-inositol, 4-amino-1,4-dideoxy-3-o-(2,6-diamino-2,3,4,6,7-pentadeoxy-beta-L-lyxo-heptopyranosyl)-1-((((iminomethyl)amino)acetyl)methylamino)-6-o-methyl- | [Molecular Formula]
C18H36N6O6 | [MDL Number]
MFCD00890168 | [MOL File]
73196-97-1.mol | [Molecular Weight]
432.518 |
| Hazard Information | Back Directory | [Description]
Dactimicin is a a novel pseudodisaccharide aminoglycoside. It activities in vitro and in vivo antibacterial compared with those of other aminoglycoside antibiotics. Dactimicin was more resistant than astromicin to inactivation by aminoglycoside 3-acetyltransferase, probably owing to the protective action of the formimidoyl group. | [Uses]
Dactimicin is a pseudodisaccharide aminoglycoside. Dactimicin is an antibiotic that can inhibit the growth of methicillin-susceptible S. aureus isolates and coagulase-negative staphylococci with MIC50s of 2 μg/mL. Dactimicin is active against organisms possessing aminoglycoside-modifying enzymes[1]. | [References]
[1] Gu JW, et al. In vitro activity of dactimicin, a novel pseudodisaccharide aminoglycoside, compared with activities of other aminoglycosides. Antimicrob Agents Chemother. 1989 Nov;33(11):1998-2003. DOI:10.1128/AAC.33.11.1998 |
|
|